A lower-court ruling had reinstated a Food and Drug Administration requirement that patients visit a health care provider in person to obtain mifepristone.
Go to Source
Author: Ann E. Marimow
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml

